A field trial of autogenous Moraxella bovis bacterin administered through either subcutaneous or subconjunctival injection on the development of keratoconjunctivitis in a beef herd

Canadian Veterinary Journal

Volumn 44, Issue 7, 2003, Pages 577-580

  Davidson, Harriet J ^a   Stokka, Gerald L ^b  

^a KANSAS STATE UNIVERSITY   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZIMYCIN; BACTERIAL VACCINE; BACTERIN; CATTLE MASTER 4; DEXAMETHASONE; OXYTETRACYCLINE; PENICILLIN G; PILIGUARD PINKEYE 1; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATTLE DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; INFECTION PREVENTION; INOCULATION; KERATOCONJUNCTIVITIS; MALE; MORAXELLA BOVIS; NONHUMAN; RANDOMIZATION; STATISTICAL SIGNIFICANCE; VIRUS INFECTION;

ANIMALS; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; CORNEA; DRUG ADMINISTRATION ROUTES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; INJECTIONS, SUBCUTANEOUS; KERATOCONJUNCTIVITIS; MALE; MORAXELLA (MORAXELLA) BOVIS; RANDOM ALLOCATION; SEX FACTORS; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS; MORAXELLA BOVIS;

EID: 0041632371     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. George LW. Clinical infectious bovine keratoconjunctitis. Compend Contin Educ Pract Vet 1984;6:712-720.
2. Webber JJ, Selby LA. Risk factors related to the prevalence of infectious bovine keratoconjunctivitis. J Am Vet Med Assoc 1981;179:823-826.
3. Slatter DH, Edward ME, Hawkins CD, Wilcox GE. A national survey of the clinical features, treatment and importance of infectious bovine keratoconjunctivitis. Aust Vet J 1982;59:69-72.
4. Brown MH, Brightman AH, Fenwick BW, Rider MA. Infectious bovine keratoconjunctivitis: A review. J Vet Intern Med 1998;12: 259-266.
5. Ward J, Nielson M. Pinkeye (bovine infectious keratoconjunctivitis) in beef cattle. J Anim Sci 1979;8:361-366.
6. Zielinski G, Piscitelli H, Perez-Monti H, Stobbs LA. Antibiotic sensitivity of an argentine strain collection of Moraxella bovis. Vet Therapeutics 2000;1:999-204.
7. Smith PC, Blankenship T, Hoover TR, Powe, Wright JC. Effectiveness of two commercial infectious bovine keratoconjunctivitis vaccines. Am J Vet Res 1990;51:1147-1150.
8. Arora AK, Killinger AH, Mansfield ME. Bacteriologic and vaccination studies in a field epizootic of infectious bovine keratoconjunctivitis in calves. Am J Vet Res 1976;37:803-806.
9. Lepper AWD, Elleman TC, Hoyne PA, et al. A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis. Vet Microbiol 1993;36:175-193.
10. Gerber JD, Selzer NL, Sharpee RL, Beckenhauer WH. Immunogenicity of a Moraxella bovis bacterin containing attachment and cornea-degrading enzyme antigens. Vet Immunol Immunopathol 1988;18:41-52.
11. Angelos JA, Hess JF, George LW. Cloning and characterization of a Moraxella bovis cytotoxin gene. Am J Vet Res 2001;62: 1222-1228.
12. Montgomery PC, Whittum-Hudson J. Mucosal immunity in the ocular system, In: Kiyonon H, Ogra PL, McGhee JR, eds. Mucosal Vaccines. San Diego: Academic Pr, 1996:403-423.
13. Quinn PJ, Cater ME, Markey BK, Carter GR. Clinical Veterinary Microbiology, London: Wolfe-Mosby, 1994:284-286.
14. Carter GR, Chengappa MM, Roberts AW. Essentials of Veterinary Microbiology 5th ed. Media, Pennsylvania: Williams & Wilkins, 1995:194-198.
15. Pocock SJ. Clinical Trials a Practical Approach. Chichester, UK: John Wiley, 1998:60-61.
16. Smith P, Greene W. Antibodies related to resistance in bovine pinkeye. Calif Vet 1989;14:7-9.
17. Nayar P, Saunders J. Infectious bovine keratoconjunctivitis II. Antibodies in lacrimal secretions of cattle naturally or experimentally infected with Moraxella bovis. Can J Comp Med 1975;39: 32-40.
18. Walker RI. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994;12:387-400.
19. Misiura M. Estimation of fimbrial vaccine effectiveness in protection against keratoconjunctivitis infectiosa in calves considering different routes of introducing vaccine antigen. Arch Vet Polonicum 1994;34:177-185.
20. Powe T, Nusbaum K. Prevalence of nonclinical Moraxella bovis infections in bulls as determined by ocular culture and serum antibody titer. J Vet Diagn Invest 1992;4:78-79.
21. Gerds S. Examination of changes in the tear protein profile of calves after vaccination against infectious bovine keratoconjunctivitis by high performance liquid chromatography (Doctorate dissertation). Giessen, Germany: Justus-Liebig-University Giessen, 1996.
22. Marcozzi G, Madia F, DelBianco G, Mattei E, deFeo G. Lacrimal fluid peroxidase activity during the menstrual cycle. Curr Eye Res 2000;20:178-182.
23. Sullivan DA, Sullivan BD, Ullman MD, et al. Androgen influence on the meibomian gland. Invest Oplithalmol Vis Sci 2000;41: 3732-3742.
24. McClellan KA, Robertson FG, Kindblom J, et al. Investigation of the role of prolactin in the development and function of the lacrimal and Harderian glands using genetically modified mice. Invest Ophthalmol Vis Sci 2001;42:23-30.
25. Sullivan DA. Influence of gender, sex steroid hormones, and the hypothalamic-pituitary axis on the structure and function of the lacrimal gland. In: Sullivan DA, Dartt DA, eds. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. New York: Plenum Pr 1996:11-42.
26. Mircheff AK, Warren DW, Wood RL. Hormonal support of lacrimal function, primary lacrimal deficiency, autoimmunity and peripheral tolerance in the lacrimal gland. Ocul Immunol Inflamm 1996;4:3:145-172.
27. Nelson JD. A clinician looks at the tear film. In: Sullivan DA, Dartt DA, eds. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. New York: Plenum Pr 1996: 1-10.
28. Midelfart A. Women and Men - same eyes? Acta Ophthalmol Scand 1996;74:589-592.
29. Hart WM. The Eyelids. In: Hart WM, ed. Adler's Physiology of the Eye: Clinical Application, 9th ed. London: Mosby 1992:9.